Imagine following a recipe but getting a different cake every time because the instructions are vague. This project fixes that for science by making sure research steps are clear and repeatable. It creates a set of rules and a dashboard to prove that a discovery is real and not just a fluke.
Companies waste significant capital on R&D that cannot be replicated, often due to poor reporting and a focus on quantity over quality. This leads to a loss of trust in scientific outcomes and inefficient resource allocation.
The project produced a set of published protocols on OSF and an observatory dashboard to track reproducibility indicators.
If you are a drug discovery firm dealing with failed clinical trials due to non-reproducible early lab results — this project developed evidence-based solutions and protocols that ensure research quality. This reduces the waste of time and resources on ineffective interventions.
If you are a CRO dealing with clients questioning the reliability of your study outcomes — this project developed an observatory dashboard of indicators for reproducible research. This provides a way to prove the reliability of your data to external auditors.
If you are an AI lab dealing with 'black box' results that cannot be replicated by other teams — this project developed guidance for judging reproducibility. This helps in creating a standard for validating algorithmic performance across different environments.
Based on available project data, there is no pricing mentioned as the project focuses on open knowledge bases and Open Access publications.
The project aims to make these practices widely accepted and recognized globally by 2026, suggesting a goal of broad scalability across research systems.
Based on available project data, the project emphasizes Open Science and Open Access, meaning results are likely intended for public use rather than restrictive licensing.
It integrates by embedding reproducibility into the design of research projects and providing dashboards of indicators for researchers and funders to use during assessment.
The project period runs from 2023-01-01 to 2026-12-31.
The consortium is heavily academic, consisting of 9 partners from 7 countries, including 5 universities and 3 research organizations. There is a 0% industry ratio, meaning the project is driven by public research interests rather than immediate commercial application, though it targets funders and publishers as key users.
Contact Universitaire Medisch Centrum Utrecht
Contact us to find out how to apply these reproducibility standards to your R&D pipeline.
